Orizo Pharma Private Limited

Founded in 2022 and headquartered in Telangana, India.

2022 | Hyderabad, Telangana (India) | Active
Last Updated:

Orizo Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.70 Cr
  • Paid Up Capital ₹ 1.70 Cr
  • Company Age 3 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth %
  • Profit Growth 99.79%
  • Ebitda 99.79%
  • Net Worth -0.11%
  • Total Assets -0.11%

About Orizo Pharma

Orizo Pharma Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 January 2022 (Three years and four months 4 days old ). Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.70 Cr, as per Ministry of Corporate Affairs (MCA) records.

Amol Walke, Zubin Gandhi, Punit Thakrar, and One other member serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24290TG2022PTC158573

  • Company No.

    158573

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    06 Jan 2022

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma
Company report

Orizo Pharma Private Limited

Explore comprehensive data for Orizo Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Orizo Pharma?

Board Members (4)

NameDesignationAppointment DateStatus
Amol Walke Country flag representing In Director 24-May-2023Current
Zubin Gandhi Country flag representing In Director 24-May-2023Current
Punit Thakrar Country flag representing In Director 24-May-2023Current
Yatin Desai Country flag representing In Director 24-May-2023Current

Financial Performance of Orizo Pharma.

Orizo Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.79% increase in profit. The company's net worth dipped by a decrease of 0.11%.

Orizo Pharma revenue growth over time
Orizo Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-0.11%
Profit or Loss
99.79%
Net Worth
-0.11%
EBITDA
99.79%

What is the Ownership and Shareholding Structure of Orizo Pharma?

Unlock access to Orizo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Orizo Pharma?

Orizo Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Orizo Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orizo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orizo Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Orizo Pharma

Recent activity within the organization

  • Annual General Meeting

    Orizo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Orizo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Director Appointment

    Amol Ashok Walke was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 1 year 11 months .

  • Director Appointment

    Zubin Keki Gandhi was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 1 year 11 months .

  • Director Appointment

    Punit Chunilal Thakrar was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 1 year 11 months .

  • Director Appointment

    Yatin Kirtanlal Desai was appointed as a Director was appointed as a Director on 24 May 2023 & has been associated with this company since 1 year 11 months .

Frequently asked questions

  • What is the Incorporation or founding date of Orizo Pharma Private Limited?

    Orizo Pharma Private Limited was incorporated on 06 Jan 2022.

  • What is authorized share capital and paid-up capital of Orizo Pharma Private Limited?

    The authorized share capital of Orizo Pharma Private Limited is ₹ 1.70 Cr and paid-up capital is ₹ 1.70 Cr.

  • Who are the current board members & directors of Orizo Pharma Private Limited?

    Currently 4 directors are associated with Orizo Pharma Private Limited.

    • Amol Ashok Walke
    • Zubin Keki Gandhi
    • Punit Chunilal Thakrar
    • Yatin Kirtanlal Desai

  • What is the registered address of Orizo Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Orizo Pharma Private Limited is 1217/A Veda Ark 3Rd Floor Road No 36 Jubilee Hills, India, Hyderabad, Telangana, 500033.

  • What is the corporate identification number (CIN) and company number of Orizo Pharma Private Limited?

    The corporate identification number (CIN) of Orizo Pharma Private Limited is U24290TG2022PTC158573 and the company number is 158573 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Orizo Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Orizo Pharma Private Limited has experienced an downturn of -0.11%.

  • When was the last Balance Sheet of Orizo Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Orizo Pharma Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development